Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to see whether treatment with a thyroid hormone, called
triiodothyronine or T3, following open heart surgery reduces the risk of developing atrial
fibrillation.